Skip to main content
Home
    • ALL Specialities ALL Specialities
    Home
    Home

    Hagop Kantarjian et al

    Article

    Use of the JAK1/JAK2 inhibitor ruxolitinib in the treatment of patients with myelofibrosis

    Author:
    Hagop Kantarjian et al
    • Read More

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties